company higHlights 

0
Opportunities Evaluated
0
Investments Made
0
Implied historical return
on invested capital1
0
2020E attributable
EBITDA from joint ventures2
0
Indicative value
of public and private
venture investments3
0
Cash for
future investments4
 
 
 
1Based on most recently published average analyst NAV (adjusted for capitalized G&A expenses and cash on hand).
2Representsupper end of estimated proportionate EBITDA for joint venture investments PharmHouse and Vert Mirabel for CY 2020 based on Investee’s projections and Canopy Rivers’ ownership stake.
3Represents indicative value for select public and private venture investments as at June 30, 2019.
4Approximately $60 MM unencumbered and available for new investments.
ABOUT-BACKGROUND_blue.jpg